Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Cellect Biotechnology Ltd. for the month of May 2017. The filing documents the outcome of the company's annual general meeting of ordinary shareholders and ADS holders, which was convened on April 30, 2017.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance data.
Material Changes
At the annual general meeting held on April 30, 2017, the registrant's ordinary shareholders and ADS holders passed all agenda items as originally proposed. These items were previously described in Exhibit 99.1 to a Form 6-K furnished on March 22, 2017.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, specific risks, contingencies, or unusual items. The document notes that this Form 6-K is incorporated by reference into the registration statement on Form S-8 (Registration No. 333-214817).
Key Facts for Investors to Verify
- Confirmation that all agenda items from the April 30, 2017, annual general meeting were approved by shareholders.
- Review of Exhibit 99.1 (filed March 22, 2017) for details on the specific agenda items passed.
- Verification of the incorporation of this report into Form S-8 (Registration No. 333-214817).